Pyoderma gangrenosum: A review

Journal of Cutaneous Pathology

Volumn 30, Issue 2, 2003, Pages 97-107

  Crowson, A Neil ^a,b   Mihm Jr , Martin C ^c   Magro, Cynthia ^d  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b ST JOHN MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; PATHOGENESIS; PYODERMA GANGRENOSUM; REVIEW; SKIN BIOPSY;

ADULT; CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; MIDDLE AGED; PYODERMA GANGRENOSUM; SWEET'S SYNDROME;

EID: 0037303558     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2003.00024.x     Document Type: Review

References (157)

1. Brunsting LA, Goeckerman WH, O'Leary PA. Pyoderma gangenosum: clinical and experimental observations in five cases occurring in adults. Arch Dermatol 1930; 22: 655.
2. Schwartz BK, Clendenning WE, Blasik LG. Pyoderma gangrenosum in a patient with HTLV-III antibody. Arch Dermatol 1986; 122: 508.
3. Powell FC, Schroeter AL, Su WPD et al. Pyoderma gangrenosum and sarcoidosis. Arch Dermatol 1984; 120: 959.
4. Bundino S, Zina AM. Pyoderma gangrenosum associated with selective hereditary IgA deficiency. Dermatologica 1984; 168: 230.
5. Van de Kerkhof PCM, Vaan GAM, Holland R. Pyoderma gangrenosum in acute myeloid leukemia during immunosuppression. Eur J Pediatr 1988; 148: 34.
6. Blanc D, Schreiber M, Racadot E et al. Pyoderma gangrenosum in an allogenic bone marrow transplant recipient. Clin Exp Dermatol 1989; 14: 376.
7. Haim S, Bimbaum RF. Pyoderma gangrenosum in immunosuppressed patients. Dermatologica 1976; 153: 44.
8. Paller AS, Sahn EE, Garen PD et al. Pyoderma gangrenosum in pediatric acquired immunodeficiency syndrome. J Pediatr 1990; 117: 63.
9. Wines N, Wines M, Ryman W. Understanding pyoderma gangrenosum: a review. Med General Med 2001; 27: 6.
10. Powell FC, Schroeter AL, Su WPD et al. Pyoderma gangrenosum: a review of 86 patients. QJ Med 1985; 55: 173.
11. Powell FC, Su WPD, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 1996; 34: 395.
12. Tay CH. Pyoderma gangrenosum and leukemia. Arch Dermatol 1973; 108: 580.
13. Duguid CM, Otridge B, Powell FC. Herpetiform Sweet's syndrome and leukemia. J Eur Acad Dermatol Venerol 1995; 5: 279.
14. Jacobs P, Palmer S, Gordon-Smith EC. Pyoderma gangrenosum in myelodysplasia and acute leukemia. Post-Grad Med J 1985; 61: 689.
15. Ho KK-L, Otridge B, Vandenberg E et al. Pyoderma gangrenosum, polycythemia rubra vera, and the development of leukemia. J Am Acad Dermatol 1992; 27: 804.
16. Powell FC, Schroeter AL, Su WPD et al. Pyoderma gangrenosum and monoclonal gammopathy. Arch Dermatol 1983; 119: 468.
17. Moller H, Waldenstrom JG, Kettervall O. Pyoderma gangrenosum (dermatitis ulcerosa) and monoclonal (IgA) globulin healed after melphalan treatment. Acta Med Scand 1978; 203: 293.
18. Carsuzaa F, Pierre C, Dubegny M. Pyoderma gangrenosum et haemopathie a IgA: association a une gastrite atrophique. Ann Dermatol Venereol 1989; 116: 707.
19. Sanchez YE, Cabre J. 'Pyoderma gangrenosum' (P.G.) con mieloma IgA lambda y defcit de la immunidad celular. Actas Dermosifiligr 1980; 71: 35.
20. Chevrant-Breton J, Logeais B, Pibouin N.'Pyoderma gangrenosum' (pyodermite phagedenique). Ann Dermatol Venerol 1989; 116: 577.
21. Transactions of the Michigan Dermatological Society. Pyoderma gangrenosum and Hodgkin's lymphoma. Arch Dermatol 1974; 109: 269.
22. Mahood JM, Sneddon IB. Pyoderma gangrenosum complicating non-Hodgkin's lymphoma. Br J Dermatol 1980; 102: 233.
23. Kitahama A, Roland TY, Kerstein MD. Pyoderma gangrenosum with cutaneous T-cell lymphoma manifested as lower extremity ulcers: case reports. Angiology 1991; 42: 498.
24. Philpot JA, Goltz RW, Park RK. Pyoderma gangrenosum, rheumatoid arthritis and diabetes mellitus. Arch Dermatol 1972; 105: 46.
25. Olson K. Pyoderma gangrenosum with systemic lupus erythematosus. Acta DermVenereol (Stockh) 1971; 51: 233.
26. Spangler JG. Pyoderma gangrenosum in a patient with psoriatic arthritis. J Am Board Fam Pract 2001; 14: 466.
27. Goreti Catorze M, Pereira F, Fonseca F, Morbey A, Assis Pacheco F. Pyoderma gangrenosum associated with sclerosing cholangitis, type 1 diabetes mellitus and ulcerative colitis. J Eur Acad Dermatol Venereol 2001; 15: 257.
28. Callen JP, Woo TY. Vesiculopustular eruption in a patient with ulcerative colitis. Arch Dermatol 1985; 121: 399.
29. Magro CM, Crowson AN. A distinctive vesiculopustular eruption associated with hepatobiliary disease. Int J Dermatol 1997; 36: 837.
30. Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964; 76: 349.
31. Requena L, Sanchez-Yus E, Martin L et al. Erythema elevatum diutinum in a patient with acquired immunodeficiency syndrome. Arch Dermatol 1991; 127: 1819.
32. Yiannias JA, el-Azhary RA, Gibson LE. Erythema elevatum diutinum: a clinical and histopathologic study of 13 cases. J Am Acad Dermatol 1992; 26: 38.
33. Wilkinson S, English JSC, Smith NP et al. Erythema elevatum diutinum: a clinicopathologic study. Clin Exp Dermatol 1992; 17: 87.
34. Buahene K, Hudson M, Mowat A et al. Erythema elevatum diutinum: an unusual association with ulcerative colitis. Clin Exp Dermatol 1991; 16: 204.
35. Walker KD, Badame AJ. Erythema elevatum diutinum in a patient with Crohn's disease. J Am Acad Dermatol 1990; 22: 948.
36. Planaguma M, Puig L, Alomar A et al. Pyoderma gangrenosum in association with erythema elevatum diutinum: report of two cases. Cutis 1992; 49: 201.
37. Srebrnik A, Schachar E, Brenner S. Suspected induction of a pyoderma gangrenosum-like eruption due to sulpride treatment. Cutis 2001; 67: 253.
38. Ross HJ, Moy LA, Kaplan R et al. Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment. Cancer 1991; 68: 441.
39. Sau M, Hill NC. Pyoderma gangrenosum of the vulva. Br J Obstet Gynaecol 2001; 108: 1197.
40. Wernikoff S, Merritt C, Briggaman RA et al. Malignant pyoderma or pyoderma gangrenosum of the head and neck? Arch Dermatol 1987; 123: 371.
41. Malkinson FD. Pyoderma gangrenosum vs. malignant pyoderma, lumpers vs. splitters. Arch Dermatol 1987; 123: 333.
42. Perry HO, Winkelmann RD, Muller SA et al. Malignant pyodermas. Arch Dermatol 1968; 98: 561.
43. Dicken CH. Malignant pyoderma. J Am Acad Dermatol 1985; 13: 1021.
44. Powell FC, Winkelmann RK. Malignant pyoderma. Br J Dermatol 1983; 109: 587.
45. Gungor E, Karakayali G, Alli N, Artuz F, Lenk N. Penile pyoderma gangrenosum. J Eur Acad Dermatol Venereol 1999; 12: 59.
46. Farrell AM, Black MM, Bracka A, Bunker CB. Pyoderma gangrenosum of the penis. Br J Dermatol 1998; 138: 337.
47. Dolan OM, Burrows D, Walsh M. Pyoderma gangrenosum of the breast treated with low dose cyclosporine A. Clin Exp Dermatol 1997; 22: 92.
48. Lebbe C, Moulonguet-Michau I, Perrin P et al. Steroid responsive pyoderma gangrenosum with vulvar and pulmonary involvement. J Am Acad Dermatol 1992; 27: 623.
49. O'Loughlin S, Perry HO. A diffuse pustular eruption associated with ulcerative colitis. Arch Dermatol 1978; 114: 1061.
50. Basler MD, Dubin HV. Ulcerative colitis and the skin. Arch Dermatol 1976; 112: 531.
51. Levitt MD, Ritchie JK, Lennard-Jones JE et al. Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg 1991; 78: 676.
52. Kang S, Dover JS. Successful treatment of eruptive pyoderma gangrenosum with intravenous vanocmycin and mezlocillin. Br J Dermatol 1990; 123: 389.
53. Dicken CH, Seehafer JR. Bowel bypass syndrome. Arch Dermatol 1979; 115: 837.
54. Dicken CH. Bowel-associated dermatosis-arthritis syndrome: bowel bypass. J Am Acad Dermatol 1986; 14: 792.
55. Delaney TA, Clay CD, Randell PL. The bowel-associated dermatosis-arthritis syndrome. Australas J Dermatol 1989; 30: 23.
56. Callen JP. Acute febrile neutrophilic dermatosis (Sweet's syndrome) and the related conditions of 'bowel bypass' syndrome and bullous pyoderma gangrenosum. Dermatol Clin 1985; 3: 153.
57. Von den Driesch P. Sweet's syndrome: pathogenesis and associated conditions [Letter]. J Am Acad Dermatol 1991; 25: 577.
58. Jorizzo JL, Solomon AR, Zanolli MD, Zanolli MD, Leshin B. Neutrophilic vascular reactions. J Am Acad Dermatol 1988; 19: 983.
59. Jorizzo JL, Apisarnthanarax P, Subrt P et al. Bowel-bypass syndrome without bowel bypass. Bowel-associated dermatosis-arthritis syndrome. Arch Intern Med 1983;143:457.
60. Powell FC, Perry HO. Pyoderma gangrenosum in childhood. Arch Dermatol 1984; 120: 757.
61. Cox NH, Peebles-Brown DA, MacKie RM. Pyoderma gangrenosum occurring 10 years after proctocolectomy for ulcerative colitis. Br J Hosp Med 1986; 36: 363.
62. van Hale R, Rogers RS, Zone JJ. Pyostomatitis vegetans: a reactive mucosal marker for inflammatory bowel disease of the gut. Arch Dermatol 1985; 121: 94.
63. Neville BW, Smith E, Maize JC et al. Pyostomatitis vegetans. Am J Dermatopathol 1985; 7: 67.
64. Ballo FS, Camisa C, Allen CM. Pyostomatitis vegetans. J Am Acad Dermatol 1989; 21: 381.
65. Grob JJ, Mege JL, Prax AM et al. Disseminated pustular dermatosis in polycythemia vera. J Am Acad Dermatol 1988; 18: 1212.
66. Perry HO, Winkelmann RK. Bullous pyoderma gangrenosum and leukaemia. Arch Dermatol 1972; 106: 901.
67. Prystowsky JH, Kahn SN, Lazarus GS. Present status of pyoderma gangrenosum: review of 21 cases. Arch Dermatol 1989; 125: 57.
68. Goldin D. Pyoderma gangrenosum with chronic myeloid leukemia. Proc Royal Soc Med 1974; 67: 1239.
69. Crow KD, Bowers RE. Bullous hemorrhagic ulceration, a variant of pyoderma gangrenosum. Trans St Johns Hosp Dermatol Soc 1974; 60: 142.
70. Bernengo MG, Leigheb G, Zina G. A case of acute promyelocytic leukemia with bullous, hemorrhagic, necrotic skin lesions. Dermatologica 1975; 151: 184.
71. Cramers M. Bullous pyoderma gangrenosum in association with myeloid leukemia. Acta DermVenereol (Stockh) 1976; 56: 311.
72. Burton JL. Bullous pyoderma of leukemia. Br J Dermatol 1976; 95: 209.
73. Callen JP, Dubin HV, Gehrke CF. Recurrent pyoderma gangrenosum and agnogenic myeloid metaplasia. Arch Dermatol 1977; 113: 1585.
74. Sheps M, Shapero H, Ramsay C. Bullous pyoderma gangrenosum and acute leukemia. Arch Dermatol 1978; 114: 1842.
75. Lewis SJ, Poh-Fitzpatrick MB, Walther RR. Atypical pyoderma gangrenosum with leukemia. J Am Med Assoc 1978; 239: 935.
76. Wahba A, Cohen HA. Herpes simplex virus isolation from pyoderma gangrenosum lesions in a patient with chronic lymphatic leukemia. Dermatologica 1979; 158: 373.
77. Romano J, Safai B. Pyoderma gangrenosum and myeloproliferative disorders. Arch Intern Med 1979; 139: 932.
78. Lewis JE. Bullous pyoderma gangrenosum with chronic myelogenous leukemia: a report of a case. Cutis 1980; 25: 82.
79. Caughman W, Stern R, Haynes H. Neutrophilic dermatosis of myeloproliferative disorders. J Am Acad Dermatol 1983; 9: 751.
80. Goldstein BJ, Hanna K. Bullous skin ulceration in man with myelofibrosis. Hosp Pract (OffEd) 1986; 21: 102.
81. Kanel KT, Kroboth FJ, Swartz WM. Pyoderma gangrenosum with myelofibrosis. Am J Med 1987; 82: 1031.
82. Hay CRM, Messenger AG, Cotton DWK et al. Atypical bullous pyoderma gangrenosum associated with myeloid malignancies. J Clin Pathol 1987; 40: 387.
83. Gillman AG, Cohen BA, Urbach AH et al. Pyoderma gangrenosum as a manifestation of leukemia in childhood. Pediatrics 1988; 81: 846.
84. Cooper PH, Innes DJ, Greer KE. Acute febrile neutrophilic dermatosis (Sweet's syndrome) and myeloproliferative disorders. Cancer 1983; 51: 1518.
85. Hicsonmez G, Cetin M, Yenicesu I et al. Evaluation of children with myelodysplastic syndrome: importance of extramedullary disease as a presenting symptom. Br J Dermatol 2002; 42: 665.
86. Vazquez Garcia J, Almagro Sanchez M, Fonseca Capdevila E. Multiple neutrophilic dermatoses in myelodysplastic syndrome. Clin Exp Dermatol 2001; 26: 398.
87. Koester G, Tarnower A, Levisohn D, Burgdorf W. Bullous pyoderma gangrenosum. J Am Acad Dermatol 1993; 29: 875.
88. Marsden JR, Millard LG. Pyoderma gangrenosum, subcorneal pustular dermatosis and IgA paraproteinaemia. Br J Dermatol 1986; 114: 125.
89. Kohl PK, Hartschuh W, Tilgen W et al. Pyoderma gangrenosum followed by subcorneal pustular dermatosis in a patient with IgA paraproteinemia. J Am Acad Dermatol 1991; 24: 325.
90. Horton JJ, Trounce JR, MacDonald DM. Bullous pyoderma gangrenosum and multiple myeloma. Br J Dermatol 1984; 110: 227.
91. Bennett ML, Jackson JM, Jorizzo JL et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Medicine 2000; 79: 37.
92. Lear JT, Atherton MT, Byrne JP. Neutrophilic dermatoses: pyoderma gangrenosum and Sweet's syndrome. Postgrad Med J 1997; 73: 65.
93. Wilson-Jones E, Winkelmann RK. Superficial granulomatous pyoderma: a localized vegetative form of pyoderma gangrenosum. J Am Acad Dermatol 1988; 18: 511.
94. Quimby SR, Gibson LE, Winkelmann RK. Superficial granulomatous pyoderma: clinicopatholgic spectrum. May Clin Proc 1989; 64: 37.
95. Lichter MD, Welykyj SE, Gradini R et al. Superficial granulomatous pyoderma. Int J Dermatol 1991; 30: 418.
96. Goto M, Okamoto O, Fujiwara et al. Vegetative pyoderma gangrenosum in chronic renal failure. Br J Dermatol 2002; 146: 141.
97. Keane FM, MacFarlane CS, Munn SE, Higgin EM. Pyoderma gangrenosum and hepatitis C virus infection. Br J Dermatol 1998; 139: 924.
98. Byrne JPH, Hewitt M, Summerly R. Pyoderma gangrenosum associated with chronic active hepatitis: report of two cases. Arch Dermatol 1976; 112: 1297.
99. Burns DA, Sarkany I. Active chronic hepatitis and pyoderma gangrenosum: report of a case. Clin Exp Dermatol 1979; 4: 465.
100. Marshall AW, Slonim JM, Smallwood RA et al. The association of chronic active hepatitis with pyoderma gangrenosum. Aust NZ J Med 1978; 8: 656.
101. Magro CM, Crowson AN, Mihm MC. Cutaneous manifestations of gastrointestinal disease. In: Elder DE, Johnson BE, Jaworsky C, Elenitsas R, eds. Lever's histopathology of the skin. 8th edn. Philadelphia: JB Lippincott, 1997; 353.
102. Sanders S, Tahan SR, Kwan T, Magro CM. Giant cells in pyoderma gangrenosum. J Cutan Pathol 2001; 28: 98.
103. Crowson AN, Mihm MC Jr, Nash J, Magro CM. The cutaneous manifestations of Crohn's disease in sites discontiguous from the involved gastrointestinal tract: a clinicopathological study of 28 patients (Abstract). Lab Invest 2001; 81: 67A.
104. Magro CM, Crowson AN. Sterile neutrophilic folliculitis with perifollicular vasculopathy: a distinctive cutaneous reaction pattern reflecting systemic disease. J Cutan Pathol 1998; 25: 215.
105. Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 1997; 72: 611.
106. Kemp DR. Inappropriate diagnosis of necrotizing arachnidism. Med J Aust 1990; 152: 669.
107. Sams HS, Hearth SB, Long LL et al. Nineteen documented cases of Loxosceles reculsa envenomation. J Am Acad Dermatol 2001; 44: 603.
108. Sams HS, Dunnick CA, Smith ML, King LE. Necrotic arachnidism. J Am Acad Dermatol 2001; 44: 661.
109. Levya WH, King LE. Pyoderma gangrenosum associated with antiphospholipid antibodies. Int J Dermatol 1992; 31: 588.
110. Byrd DR, el-Azhary RA, Gibson LE, Roberts GD. Sporotrichosis masquerading as pyoderma gangrenosum: case report and review of 19 cases of sporotrichosis. J Eur Acad Dermatol Venereol 2001; 15: 581.
111. Magro CM, Crowson AN. Behcet's disease. Int J Dermatol 1995; 34: 159.
112. Crowson AN, Magro CM. The pathology of cutaneous drug eruptions. Curr Probl Dermatol 2002; 14: 117.
113. Lazarus GS, Goldsmith LA, Rocklin RE et al. Pyoderma gangrenosum, altered delayed hypersensitivity, and polyarthritis. Arch Dermatol 1972; 105: 46.
114. Sourreil MP, Beylot C, Boisseau M et al. Pyodermite phagedenique de siege et des organs geniteaux chez un nourrison de un mois et dermis hypogammaglobulinemique. Bord Med 1970; 3: 2462.
115. Marcussen PV. Hypogammaglobulinemia in pyoderma gangrenosum. J Invest Dermatol 1955; 24: 275.
116. Berbis P, Mege JL, Capo C et al. Hyperimmunoglobulin E and impaired neutrophil functions in a case of pyoderma gangrenosum: effect of clofazamine [Letter]. J Am Acad Dermatol 1988; 18: 574.
117. Nerella P, Daniela A, Guido M et al. Leukocyte chemotaxis and pyoderma gangrenosum. Int J Dermatol 1985; 24: 45.
118. Norris DA, Weston WL, Thorne G et al. Pyoderma gangrenosum: abnormal monocyte function corrected in vitro with hydrocortisone. Arch Dermatol 1978; 114: 906.
119. Brandt L, Gartner I, Nilsson PG et al. Pyoderma gangrenosum associated with regional enteritis: improvement in defective granulocyte function and healing of skin lesions during administration of clofazimine. Acta Med Scand 1977; 201: 141.
120. Dick DC, MacKie RM, Patrick WJA et al. Pyoderma gangrenosum in infancy. Acta Derm Venereol (Stockh) 1982; 62: 348.
121. Bentley-Phillips DB, Cooper RC, Hallett AF. Pharmacological modulation of neutrophil phagocytic function in a patient with recurrent sepsis, pyoderma gangrenosum and impaired phagocytosis. Br J Dermatol 1982; 106: 687.
122. van de Kerkhof PCM, Weemaes CMR. Skin manifestations in congenital deficiency of leukocyte-adherence glycoproteins (CDLG). Br J Dermatol 1990; 123: 395.
123. Magro CM, De Moraes E, Burns F. Sweet's syndrome in the setting of CD34-positive acute myelogenouis leukemia treated with granulocyte colony stimulating factor: evidence for a clonal neutrophilic dermatosis. J Cutan Pathol 2001; 28: 90.
124. Montoto S, Bosch F, Estrach T et al. Pyoderma gangrenosum triggered by alpha2b-interferon in a patient with chronic granulocytic leukemia. Leuk Lymphoma 1998; 30: 199.
125. Sanders S, Busam K, Tahan SR, Johnson RA, Sachs D. Granulomatous and suppurative dermatitis at interferon alpha injection site: report of 2 cases. J Am Acad Dermatol 2002; 46: 611.
126. Chow RKP, Ho VC. Treatment of pyoderma gangrenosum. J Am Acad Dermatol 1996; 34: 1047.
127. De Cock KM, Thorne MG. The treatment of pyoderma gangrenosum with sodium cromoglycate. Br J Dermatol 1980; 102: 231.
128. Nguyen LQ, Weiner J. Treatment of pyoderma gangrenosum with benzoyl peroxide. Cutis 1977; 19: 842.
129. Sanders CJG, Hulsmans RFHJ. Successful treatment of pyoderma gangrenosum with topical 5-aminosalicylic acid. Cutis 1993; 51: 262.
130. Tsele H, Yu RC, Chu AC. Pyoderma gangrenosum - response to topical nitrogen mustard. Clin Exp Dermatol 1992; 17: 437.
131. Mrowictz U, Christophers E. Clearing of pyoderma gangrenosum by intralesional cyclosporin A [letter]. Br J Dermatol 1991; 125: 499.
132. Cave DR, Burakoff R. Pyoderma gangrenosum associated with ulcerative colitis: treatment with disodium cromoglycate. Am J Gastroenterol 1987; 82: 802.
133. Smith KC, Su W PD, Leiferman KM. Cromolyn sodium on 2% aqueous solution under an occlusive hydrocolloid dressing may be effective adjunctive treatment in management of pyoderma gangrenosum [Letter]. J Am Acad Dermatol 1987; 17: 509.
134. Johnson RB, Lazarus GS. Pulse therapy: therapeutic efficacy in the treatment of pyoderma gangrenosum. Arch Dermatol 1982; 118: 76.
135. Lovett GW, Field JP, King LE. Treatment of pyoderma gangrenosum with clofazimine. J Tenn Med Assoc 1981; 74: 567.
136. Moraes M, Russo G. Thalidomide and its dermatologic uses. Am J Med Sci 2001; 321: 321.
137. Elgart G, Stover P, Larson K et al. Treatment of pyoderma gangrenosum with cyclosporine; results in seven patients. J Am Acad Dermatol 1991; 24: 83.
138. Fradin MS, Ellis CN, Voorhee JJ. Management of patients and side effects during cyclosporine therapy for cutaneous disorders. J Am Acad Dermatol 1990; 23: 1265.
139. Matis WL, Ellis CN, Griffiths CEM et al. Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol 1992; 128: 1060.
140. Ackerman C, Abu-Elmaged K, Venkataramanam K et al. Recalcitrant psoriasis and pyoderma gangrenosum treated with FK506. J Invest Dermatol 1991; 96: 536.
141. Abu-Elmaged K, Jegasothy BV, Ackerman CD et al. Efficacy of FK506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc 1991; 23: 3328.
142. Johansson A, Moller E. Evidence that the immunosuppressive effects of KF-506 and cyclosporine are identical. Transplantation 1990; 50: 1001.
143. Breathbach SM, Wells GC, Valdimarsson H. Idiopathic pyoderma gangrenosum and impaired lymphocyte function: failure of aziothioprine and corticosteroid therapy. Br J Dermatol 1981; 104: 567.
144. Rapini RP. Cytotoxic drugs in the treatment of skin disease. Int J Dermatol 1991; 30: 313.
145. Burruss JB, Farmer ER, Callen JP. Chlorambucil is an effective corticosteroid-sparing agent for recalcitrant pyoderma gangrenosum. J Am Acad Dermatol 1996; 35: 720.
146. Callen JP, Case JD, Sager D. Chlorambucil - an effective corticosteroid sparing therapy for pyoderma gangrenosum. J Am Acad Dermatol 1989; 21: 515.
147. Rozen SM, Nahabedian MY, Manson PN. Management strategies for pyoderma gangrenosum: case report and review of literature. Ann Plast Surg 2001; 47: 310.
148. Long CC, Jessop J, Young M et al. Minimizing the risk of post-operative pyoderma gangrenosum. Br J Dermatol 1992; 127: 45.
149. Kaddoura IL, Amm C. A rationale for adjuvant surgical intervention in pyoderma gangrenosum. Ann Plast Surg 2001; 46: 23.
150. Cliff S, Holden CA, Thomas PR, Marsden RA, Harland CC. Split skin grafts in the treatment of pyoderma gangrenosum. A report of four cases. Dermatol Surg 1999; 25: 299.
151. Vereecken P, Wautrecht JC, De Dobbeleer G, Heenan M. A case of pyoderma gangrenosum stabilized with lymecycline, topical benzoyl peroxide and treated by autograft. Dermatology 1997; 195: 50.
152. Limova M, Mauro T. Treatment of pyoderma gangrenosum with cultured keratinocyte autografts. J Dermatol Surg Oncol 1994; 20: 833.
153. Davis JC, Landeen JM, Levine RA. Pyoderma gangrenosum skin grafting after preparation with hyperbaric oxygen. Plast Reconstr Surg 1987; 79: 200.
154. Wasserteh V, Bruce S, Sessoms SL et al. Pyoderma gangrenosum treated with hyperbaric oxygen therapy. Int J Dermatol 1992; 31: 594.
155. Kaminska R, Ikaheimo R, Hollmen A. Plasmapheresis and cyclophosphamide as successful treatments for pyoderma gangrenosum. Clin Exp Dermatol 1999; 24: 81.
156. Gupta AK, Shear HN, Sander DN. Efficacy of human intravenous immune globulin in pyoderma gangrenosum. J Am Acad Dermatol 1995; 32: 140.
157. Tan MH, Gordon M, Lebwohl O, George J, Lebwohl MG. Improvement of pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody. Arch Dermatol 2001; 137: 930.